Noninvasive prenatal diagnosis of Down syndrome in samples from Southwest Chinese gravidas using pregnant plasma placental RNA allelic ratio.

OBJECTIVE The purpose of this research was to attempt a preliminary study of noninvasive prenatal diagnosis of Down syndrome in Southwest Chinese gravidas by using the plasma placental RNA allelic ratio. METHODS The genotypes of the single-nucleotide polymorphisms (SNPs) located in the transcribed regions of the gene PLAC4 were detected in population samples collected in Southwest China by using polymerase chain reaction-restriction fragment length polymorphism, and SNPs with a higher heterozygosity were selected. Mass spectrometer analysis was adopted, and cases with the heterozygous SNPs on PLAC4 mRNA in maternal plasma were selected from 29 pregnancies with a euploid fetus and from 21 pregnancies with a trisomy-21 fetus, and then their RNA-SNP allelic ratios were further determined for noninvasive prenatal diagnosis of Down syndrome. RESULTS Of all 50 singleton pregnancies, 37 gravidas were found with at least one heterozygous SNP on PLAC4 mRNA in maternal plasma. Among them, 13 pregnancies with a trisomy-21 fetus were detected by the analysis of the RNA-SNP allelic ratio. CONCLUSION The plasma placental RNA allelic ratio can be used for noninvasive prenatal diagnosis of Down syndrome, if SNPs on PLAC4 mRNA in maternal plasma are heterozygous.

[1]  H. C. Fan,et al.  Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood , 2008, Proceedings of the National Academy of Sciences.

[2]  F. Crea,et al.  Noninvasive prenatal diagnosis of aneuploidy using cell‐free nucleic acids in maternal blood: promises and unanswered questions , 2008, Prenatal diagnosis.

[3]  Tak Y. Leung,et al.  Digital PCR for the molecular detection of fetal chromosomal aneuploidy , 2007, Proceedings of the National Academy of Sciences.

[4]  Charles R Cantor,et al.  Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection , 2007, Nature Medicine.

[5]  T. Lau,et al.  Racial variation in incidence of trisomy 21: survey of 57,742 Chinese deliveries. , 1998, American journal of medical genetics.

[6]  I. Sargent,et al.  Presence of fetal DNA in maternal plasma and serum , 1997, The Lancet.

[7]  M. Bronner,et al.  D21S418E identifies a cAMP-regulated gene located on chromosome 21q22.3 that is expressed in placental syncytiotrophoblast and choriocarcinoma cells. , 1993, Genomics.

[8]  K. Nicolaides,et al.  Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. , 2010, Clinical chemistry.

[9]  Invasive Prenatal Testing for Aneuploidy , 2009 .

[10]  A. Fanaroff,et al.  Digital PCR for the molecular detection of fetal chromosomal aneuploidy , 2008 .

[11]  R. Chiu,et al.  Innovations: Prenatal diagnosis: progress through plasma nucleic acids , 2007, Nature Reviews Genetics.

[12]  F. Crea,et al.  Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. , 2007, Reproductive biomedicine online.

[13]  R. Chiu,et al.  Prenatal diagnosis: progress through plasma nucleic acids. , 2007, Nature reviews. Genetics.